Rapid Micro Biosystems, Inc. (RPID)
NASDAQ: RPID · Real-Time Price · USD
0.9200
-0.0010 (-0.11%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Rapid Micro Biosystems Revenue
Rapid Micro Biosystems had revenue of $8.05M in the quarter ending June 30, 2026, with 10.91% growth. This brings the company's revenue in the last twelve months to $35.18M, up 16.13% year-over-year. In the year 2025, Rapid Micro Biosystems had annual revenue of $33.59M with 19.74% growth.
Revenue (ttm)
$35.18M
Revenue Growth
+16.13%
P/S Ratio
1.31
Revenue / Employee
$205,708
Employees
171
Market Cap
46.15M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 33.59M | 5.54M | 19.74% |
| Dec 31, 2024 | 28.05M | 5.53M | 24.57% |
| Dec 31, 2023 | 22.52M | 5.39M | 31.44% |
| Dec 31, 2022 | 17.13M | -6.10M | -26.25% |
| Dec 31, 2021 | 23.23M | 7.16M | 44.50% |
| Dec 31, 2020 | 16.08M | -435.00K | -2.63% |
| Dec 31, 2019 | 16.51M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 401.95M |
| Xtant Medical Holdings | 109.53M |
| TELA Bio | 79.91M |
| CVRx, Inc. | 61.19M |
| SANUWAVE Health | 44.02M |
| QT Imaging Holdings | 26.43M |
| Sensus Healthcare | 17.51M |
| Nano-X Imaging | 15.63M |
RPID News
- 6 days ago - Rapid Micro Biosystems initiated with a Buy at Roth Capital - TheFly
- 10 days ago - Rapid Micro Biosystems Transcript: Small-Cap Virtual Conference - Transcripts
- 10 days ago - Rapid Micro Biosystems Slides: Small-Cap Virtual Conference - Filings
- 4 weeks ago - Rapid Micro Biosystems to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 1 month ago - Rapid Micro Biosystems Earnings Call Transcript: Q2 2026 - Transcripts
- 1 month ago - Rapid Micro Biosystems Earnings release: Q2 2026 - Filings
- 1 month ago - Rapid Micro Biosystems Quarterly report: Q2 2026 - Filings
- 1 month ago - Rapid Micro Biosystems reports Q2 EPS (27c), consensus (24c) - TheFly